MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Characterization of the gastrointestinal dysfunction in mice overexpressing the human mutation (A53T) of alpha-synuclein

    S. Diwakarla, R. Constable, O. Artaiz, D. Finklestein, J. Berger, J. Furness (Melbourne, Australia)

    Objective: The aim of this study was to determine if mice overexpressing the human mutation of alpha-synuclein develop gastrointestinal (GI) dysfunction, and to understand the…
  • 2018 International Congress

    Clinical subtypes of Parkinson’s disease based on nonmotor symptoms: A cluster analysis

    X. Xu, P. Chan (Beijing, China)

    Objective: To classify patients with early Parkinson's disease based on nonmotor symptoms using a data-driven approach. Background: Heterogeneity of Parkinson’s disease provides the basis for…
  • 2018 International Congress

    Improvement of Levodopa-Responsive Chronic Pain after STN-DBS in Parkinson’s disease

    A. Gera, G. Pal (Chicago, IL, USA)

    Objective: To illustrate an example of an improvement in chronic pain, following bilateral subthalamic nuclei (STN) deep brain stimulation (DBS) surgery in a Parkinson’s disease…
  • 2018 International Congress

    Smooth muscle dysfunction in the gastrointestinal system in the 6-OHDA model of Parkinson´s Disease

    P. Murillo, P. Aronsson, M. Winder, T. Carlsson (Gothenburg, Sweden)

    Objective: To explore the connection between the central dopamine system and the autonomous nervous system in GI dysfunction in PD, using animal models. Background: Gastrointestinal…
  • 2018 International Congress

    Safinamide and Rasagiline effect on motor fluctuation, sleep quality and daytime sleepiness in Parkinson’s Disease: A validated questionnaires study

    C. Liguori, A. Stefani, N. Mercuri, M. Pierantozzi (Rome, Italy)

    Objective: This is an observational study aimed at evaluating the effect of Safinamide and Rasagiline on motor fluctuations, subjective sleep and daytime sleepiness in Parkinson’s…
  • 2018 International Congress

    Clinical heterogeneity of excessive daytime sleepiness in Parkinson’s disease

    O. Levin, O. Iakovleva, M. Poluektov (Moscow, Russian Federation)

    Objective: To examine reasons and associated clinical features of excessive daytime sleepiness (EDS) in patients with Parkinson’s disease (PD). Background: Patients with EDS can divided…
  • 2018 International Congress

    Vowel characteristics associated with Parkinson’s disease in Cantonese

    N. Leung, E. Tong, M. Ng (Pokfulam, Hong Kong)

    Objective: Dopaminergic treatment has been reported to help motor problem associated with Parkinson's disease (PD), but not speech motor. The current study examined vowel articulation…
  • 2018 International Congress

    The validity of the Arabic King’s PD Pain Scale in people with Parkinson’s disease

    H. Khalil, A. Al-Sharman, N. Alissa, K. El-Salem, D. Al-Shorofat (Irbid, Jordan)

    Objective: This study aimed to examine the concurrent validity of Arabic translated version of the King's PD Pain Scale (KPPS) in people with Parkinson’s disease…
  • 2018 International Congress

    Relationship of Vitamin D deficiency with Parkinson’s disease risk

    M. Sanoeva, N. Mansurova (Bukhara, Uzbekistan)

    Objective: To study the level of vitamin D in the serum of Parkinson’s disease patients in the involvement of disease risk. Background: The Parkinson’s disease…
  • 2018 International Congress

    Predictors of freezing of gait in newly diagnosed Parkinson’s disease: Clinical, dopamine transporter imaging and CSF markers in the PPMI cohort

    R. Kim, J. Lee, H.J. Kim, A. Kim, B. Jeon, U.J. Kang, S. Fahn (Seoul, Republic of Korea)

    Objective: To examine whether clinical, dopamine transporter (DAT) imaging and cerebrospinal fluid (CSF) markers can be used to predict the later development of FOG individually…
  • « Previous Page
  • 1
  • …
  • 111
  • 112
  • 113
  • 114
  • 115
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley